After COVID-19 Fiasco, a Sign of Internal Reform at FDA?

Source: Garrison Center
by Thomas L Knapp

“In a free society, FDA would have no authority to come between doctors, patients, and medical treatment choices in the first place. Private certification mechanisms,  like those provided by Underwriters Laboratories for electrical equipment, would almost certainly do a better and cheaper job of ensuring the safety and efficacy of medications and treatments. Doctors, insurers, and most patients would likely heed the findings of such mechanisms. … Nonetheless, ‘accelerated approval’ of  aducanumab is a good sign and hopefully the beginning of a trend.” (06/08/21)